This modest uptick comes amid mixed global cues, as investors digest yesterday's record highs and ongoing FII selling pressure. Realty stocks led the gains, providing a counterbalance to declines in oil & gas, auto, and banking sectors.
In a standout performer, Sudeep Pharma shares made a blockbuster debut, listing 23% higher than the IPO price on both NSE and BSE, boosting the company's market cap to over ₹8,188 crore. The BSE Sensex and Nifty index failed to surpass their all-time closing highs from Thursday but showed resilience despite foreign outflows.
Sensex and Nifty Today: Early Gains Amid Sector Rotation
The BSE Sensex opened higher, adding 100 points or 0.12% to reach 85,630 in early deals, signaling a cautious optimism in the Indian equity market. Meanwhile, the Nifty 50 rose 20 points or 0.08%, trading around 26,230, supported by buying interest in select heavyweights.
Sector-wise, realty stocks emerged as the top gainer, buoyed by positive sentiment around infrastructure and urban development themes. However, oil and gas stocks, auto shares, and banking stocks faced headwinds, dragging down broader indices. This rotation highlights investors' shift towards defensive plays amid global uncertainties.
For real-time Sensex live updates and Nifty chart analysis, market participants are closely watching key support levels at 85,500 for Sensex and 26,100 for Nifty.
Record Highs Revisited: Thursday's All-Time Peaks After 14 Months
The Indian stock market rally gained fresh momentum on Thursday, November 27, when benchmarks scaled all-time high levels after a 14-month hiatus. During intraday trading, the Nifty 50 touched a record peak of 26,310 points, while the Sensex index surged to 86,055.
These milestones eclipse the previous highs set on September 27, 2024 – Sensex at 85,978 and Nifty at 26,277 – underscoring the bull market's resurgence driven by robust economic data and corporate earnings.
Despite the euphoria, Sensex closing today (Thursday) settled 110 points higher at 85,720, falling short of a new record close. The Nifty end of day added just 10 points to close at 26,215. Auto, finance, and banking sectors stole the show with strong gains, while IT and realty indices buckled under profit-taking.
Global Market Cues: Mixed Asia, US Holiday Lull
Asian stock markets presented a patchy picture, influencing Indian shares at the open. South Korea's KOSPI index tumbled 1.18%, Japan's Nikkei 225 dipped 0.045%, and Hong Kong's Hang Seng shed 0.22%, weighed down by tech sector woes and geopolitical tensions.
Across the Pacific, the US stock market remained shuttered on November 27 for Thanksgiving Day, observed on the fourth Thursday of November. Futures point to a flat open today, with investors eyeing upcoming Fed signals on interest rates.
FII vs DII: Foreign Selling Continues, Domestic Buyers Step In
Investor flows remained a focal point, with Foreign Institutional Investors (FIIs) offloading shares worth ₹1,255.20 crore in the cash segment on November 27. In contrast, Domestic Institutional Investors (DIIs) countered the pressure by scooping up equities valued at ₹3,940.87 crore.
For the month to date, FII net selling stands at a hefty ₹13,704.59 crore, reflecting caution over valuations and global risks. Meanwhile, DII investments have surged to ₹72,935.30 crore, providing crucial liquidity and stabilizing the NSE Nifty and BSE Sensex amid volatility.
Track FII DII data today for insights into market direction, as domestic buying has been a key pillar supporting the ongoing stock market recovery.
Sudeep Pharma IPO Listing: 23% Premium Sparks Investor Buzz
Adding sparkle to the session, Sudeep Pharma shares listed with a bang, debuting 23% above the IPO price. On the NSE, the stock opened at ₹730 – a 23.10% premium to the upper price band of ₹593 – while on BSE, it hit ₹725, marking a 22.26% jump.
Post-listing, Sudeep Pharma market cap swelled to ₹8,188.78 crore, reflecting strong demand for the pharma player's growth story in APIs and formulations. The robust IPO listing premium underscores investor confidence in the pharmaceutical stocks segment, which has outperformed amid export tailwinds.
For those eyeing new IPO listings 2025, Sudeep Pharma's debut highlights the sector's potential in a post-pandemic world.
Outlook: What to Watch in Indian Stock Market Today
As trading progresses, eyes will be on RBI policy hints, Q3 earnings previews, and crude oil prices impacting energy stocks. With Sensex share price and Nifty prediction in focus, analysts see upside potential if global sentiment improves, though FII outflows could cap gains.
